<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35358095</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1558-8238</ISSN><JournalIssue CitedMedium="Internet"><Volume>132</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>16</Day></PubDate></JournalIssue><Title>The Journal of clinical investigation</Title><ISOAbbreviation>J Clin Invest</ISOAbbreviation></Journal><ArticleTitle>Neutrophil extracellular traps regulate ischemic stroke brain injury.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e154225</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1172/JCI154225</ELocationID><Abstract><AbstractText>Ischemic stroke prompts a strong inflammatory response, which is associated with exacerbated outcomes. In this study, we investigated mechanistic regulators of neutrophil extracellular trap (NET) formation in stroke and whether they contribute to stroke outcomes. NET-forming neutrophils were found throughout brain tissue of ischemic stroke patients, and elevated plasma NET biomarkers correlated with worse stroke outcomes. Additionally, we observed increased plasma and platelet surface-expressed high-mobility group box 1 (HMGB1) in stroke patients. Mechanistically, platelets were identified as the critical source of HMGB1 that caused NETs in the acute phase of stroke. Depletion of platelets or platelet-specific knockout of HMGB1 significantly reduced plasma HMGB1 and NET levels after stroke, and greatly improved stroke outcomes. We subsequently investigated the therapeutic potential of neonatal NET-inhibitory factor (nNIF) in stroke. Mice treated with nNIF had smaller brain infarcts, improved long-term neurological and motor function, and enhanced survival after stroke. nNIF specifically blocked NET formation without affecting neutrophil recruitment after stroke. Importantly, nNIF also improved stroke outcomes in diabetic and aged mice and was still effective when given 1 hour after stroke onset. These results support a pathological role for NETs in ischemic stroke and warrant further investigation of nNIF for stroke therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Denorme</LastName><ForeName>Frederik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Molecular Medicine Program.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Portier</LastName><ForeName>Irina</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Molecular Medicine Program.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rustad</LastName><ForeName>John L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Molecular Medicine Program.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cody</LastName><ForeName>Mark J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Molecular Medicine Program.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Araujo</LastName><ForeName>Claudia V</ForeName><Initials>CV</Initials><AffiliationInfo><Affiliation>Molecular Medicine Program.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoki</LastName><ForeName>Chieko</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Molecular Medicine Program.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexander</LastName><ForeName>Matthew D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Neurology.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deparment of Radiology and Imaging Sciences, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grandhi</LastName><ForeName>Ramesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Deparment of Radiology and Imaging Sciences, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Utah, Salt Lake City, Utah, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dyer</LastName><ForeName>Mitchell R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neal</LastName><ForeName>Matthew D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Majersik</LastName><ForeName>Jennifer J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Neurology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yost</LastName><ForeName>Christian C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Molecular Medicine Program.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Molecular Medicine Program.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U24 NS107228</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U10 NS086606</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002538</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM119526</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 AG059892</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL163019</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Invest</MedlineTA><NlmUniqueID>7802877</NlmUniqueID><ISSNLinking>0021-9738</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024243">HMGB1 Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001930" MajorTopicYN="Y">Brain Injuries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065206" MajorTopicYN="Y">Extracellular Traps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024243" MajorTopicYN="Y">HMGB1 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hematology</Keyword><Keyword MajorTopicYN="N">Neutrophils</Keyword><Keyword MajorTopicYN="N">Platelets</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword></KeywordList><CoiStatement><b>Conflict of interest:</b> CCY authored a US patent (patent no. 10,232,023 B2, &#x201c;Methods for treatment of and prophylaxis against inflammatory disorders&#x201d;) held by the University of Utah for the use of neonatal NET-inhibitory factors, for which PEEL Therapeutics Inc. holds the exclusive license. CCY has also received research support in excess of $50,000 from PEEL Therapeutics.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>31</Day><Hour>17</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35358095</ArticleId><ArticleId IdType="pmc">PMC9106355</ArticleId><ArticleId IdType="doi">10.1172/JCI154225</ArticleId><ArticleId IdType="pii">154225</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Virani SS, et al. Heart disease and stroke statistics&#x2014;2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254&#x2013;e743.</Citation><ArticleIdList><ArticleId IdType="pubmed">33501848</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy DJ, et al. Long-term outcomes of mechanical thrombectomy for stroke: a meta-analysis. ScientificWorldJournal. 2019;2019:7403104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6521543</ArticleId><ArticleId IdType="pubmed">31186620</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsanos AH, et al. Mortality risk in acute ischemic stroke patients with large vessel occlusion treated with mechanical thrombectomy. J Am Heart Assoc. 2019;8(21):e014425. doi: 10.1161/JAHA.119.014425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.119.014425</ArticleId><ArticleId IdType="pmc">PMC6898819</ArticleId><ArticleId IdType="pubmed">31657277</ArticleId></ArticleIdList></Reference><Reference><Citation>de Meyer SF, et al. Thromboinflammation in stroke brain damage. Stroke. 2016;47(4):1165&#x2013;1172. doi: 10.1161/STROKEAHA.115.011238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.115.011238</ArticleId><ArticleId IdType="pubmed">26786115</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol. 2021;18(9):666&#x2013;682. doi: 10.1038/s41569-021-00552-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-021-00552-1</ArticleId><ArticleId IdType="pmc">PMC8100938</ArticleId><ArticleId IdType="pubmed">33958774</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinod K, Deppermann C. Immunothrombosis and thromboinflammation in host defense and disease. Platelets. 2021;32(3):314&#x2013;324. doi: 10.1080/09537104.2020.1817360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09537104.2020.1817360</ArticleId><ArticleId IdType="pubmed">32896192</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorvillo N, et al. Extracellular DNA NET-works with dire consequences for health. Circ Res. 2019;125(4):470&#x2013;488. doi: 10.1161/CIRCRESAHA.119.314581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.119.314581</ArticleId><ArticleId IdType="pmc">PMC6746252</ArticleId><ArticleId IdType="pubmed">31518165</ArticleId></ArticleIdList></Reference><Reference><Citation>von Br&#xfc;hl ML, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med. 2012;209(4):819&#x2013;835. doi: 10.1084/jem.20112322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20112322</ArticleId><ArticleId IdType="pmc">PMC3328366</ArticleId><ArticleId IdType="pubmed">22451716</ArticleId></ArticleIdList></Reference><Reference><Citation>Brill A, et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost. 2012;10(1):136&#x2013;144. doi: 10.1111/j.1538-7836.2011.04544.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2011.04544.x</ArticleId><ArticleId IdType="pmc">PMC3319651</ArticleId><ArticleId IdType="pubmed">22044575</ArticleId></ArticleIdList></Reference><Reference><Citation>Laridan E, et al. Neutrophil extracellular traps in ischemic stroke thrombi. Ann Neurol. 2017;82(2):223&#x2013;232. doi: 10.1002/ana.24993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24993</ArticleId><ArticleId IdType="pubmed">28696508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ducroux C, et al. Thrombus neutrophil extracellular traps content impair tPA-induced thrombolysis in acute ischemic stroke. Stroke. 2018;49(3):754&#x2013;757. doi: 10.1161/STROKEAHA.117.019896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.019896</ArticleId><ArticleId IdType="pubmed">29438080</ArticleId></ArticleIdList></Reference><Reference><Citation>Vall&#xe9;s J, et al. Neutrophil extracellular traps are increased in patients with acute ischemic stroke: prognostic significance. Thromb Haemost. 2017;117(10):1919&#x2013;1929. doi: 10.1160/TH17-02-0130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH17-02-0130</ArticleId><ArticleId IdType="pubmed">28837206</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim H, et al. Evaluation of neutrophil extracellular traps as the circulating marker for patients with acute coronary syndrome and acute ischemic stroke. J Clin Lab Anal. 2020;34(5):e23190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7246366</ArticleId><ArticleId IdType="pubmed">31907963</ArticleId></ArticleIdList></Reference><Reference><Citation>Demyanets S, et al. Surrogate markers of neutrophil extracellular trap formation are associated with ischemic outcomes and platelet activation after peripheral angioplasty and stenting. J Clin Med. 2020;9(2):304. doi: 10.3390/jcm9020304.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020304</ArticleId><ArticleId IdType="pmc">PMC7073960</ArticleId><ArticleId IdType="pubmed">31979010</ArticleId></ArticleIdList></Reference><Reference><Citation>Otxoa-de-Amezaga A, et al. Location of neutrophils in different compartments of the damaged mouse brain after severe ischemia/reperfusion. Stroke. 2019;50(6):1548&#x2013;1557. doi: 10.1161/STROKEAHA.118.023837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.118.023837</ArticleId><ArticleId IdType="pubmed">31084324</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a-Mart&#xed;nez C, et al. Pharmacological modulation of neutrophil extracellular traps reverses thrombotic stroke tPA (tissue-type plasminogen activator) resistance. Stroke. 2019;50(11):3228&#x2013;3237. doi: 10.1161/STROKEAHA.119.026848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.119.026848</ArticleId><ArticleId IdType="pubmed">31526124</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-de-Puig I, et al. Neutrophil recruitment to the brain in mouse and human ischemic stroke. Acta Neuropathol. 2015;129(2):239&#x2013;257. doi: 10.1007/s00401-014-1381-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1381-0</ArticleId><ArticleId IdType="pubmed">25548073</ArticleId></ArticleIdList></Reference><Reference><Citation>Denorme F, et al. Brothers in arms: platelets and neutrophils in ischemic stroke. Curr Opin Hematol. 2021;28(5):301&#x2013;307. doi: 10.1097/MOH.0000000000000665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOH.0000000000000665</ArticleId><ArticleId IdType="pmc">PMC8483595</ArticleId><ArticleId IdType="pubmed">34183536</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel S, et al. Platelet-derived HMGB1 is a critical mediator of thrombosis. J Clin Invest. 2015;125(12):4638&#x2013;4654. doi: 10.1172/JCI81660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI81660</ArticleId><ArticleId IdType="pmc">PMC4665785</ArticleId><ArticleId IdType="pubmed">26551681</ArticleId></ArticleIdList></Reference><Reference><Citation>Maugeri N, et al. Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J Thromb Haemost. 2014;12(12):2074&#x2013;2088. doi: 10.1111/jth.12710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12710</ArticleId><ArticleId IdType="pubmed">25163512</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanai H, et al. Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection. Proc Natl Acad Sci U S A. 2013;110(51):20699&#x2013;20704. doi: 10.1073/pnas.1320808110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1320808110</ArticleId><ArticleId IdType="pmc">PMC3870753</ArticleId><ArticleId IdType="pubmed">24302768</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin G, et al. Durable and controlled depletion of neutrophils in mice. Nat Commun. 2020;11(1):2762. doi: 10.1038/s41467-020-16596-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16596-9</ArticleId><ArticleId IdType="pmc">PMC7265525</ArticleId><ArticleId IdType="pubmed">32488020</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh V, et al. HMGB1 as a key mediator of immune mechanisms in ischemic stroke. Antioxid Redox Signal. 2016;24(12):635&#x2013;651. doi: 10.1089/ars.2015.6397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2015.6397</ArticleId><ArticleId IdType="pubmed">26493086</ArticleId></ArticleIdList></Reference><Reference><Citation>Yost CC, et al. Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. Blood. 2009;113(25):6419&#x2013;6427. doi: 10.1182/blood-2008-07-171629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2008-07-171629</ArticleId><ArticleId IdType="pmc">PMC2710935</ArticleId><ArticleId IdType="pubmed">19221037</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell RA, et al. Placental HTRA1 cleaves &#x3b1;1-antitrypsin to generate a NET-inhibitory peptide. Blood. 2021;138(11):977&#x2013;988. doi: 10.1182/blood.2020009021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020009021</ArticleId><ArticleId IdType="pmc">PMC9069473</ArticleId><ArticleId IdType="pubmed">34192300</ArticleId></ArticleIdList></Reference><Reference><Citation>Yost CC, et al. Neonatal NET-inhibitory factor and related peptides inhibit neutrophil extracellular trap formation. J Clin Invest. 2016;126(10):3783&#x2013;3798. doi: 10.1172/JCI83873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI83873</ArticleId><ArticleId IdType="pmc">PMC5096809</ArticleId><ArticleId IdType="pubmed">27599294</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher M, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009;40(6):2244&#x2013;2250. doi: 10.1161/STROKEAHA.108.541128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.108.541128</ArticleId><ArticleId IdType="pmc">PMC2888275</ArticleId><ArticleId IdType="pubmed">19246690</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med. 2010;207(9):1853&#x2013;1862. doi: 10.1084/jem.20100239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20100239</ArticleId><ArticleId IdType="pmc">PMC2931169</ArticleId><ArticleId IdType="pubmed">20733033</ArticleId></ArticleIdList></Reference><Reference><Citation>Willis VC, et al. Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis. Clin Exp Immunol. 2017;188(2):263&#x2013;274. doi: 10.1111/cei.12932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12932</ArticleId><ArticleId IdType="pmc">PMC5383440</ArticleId><ArticleId IdType="pubmed">28128853</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis HD, et al. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nat Chem Biol. 2015;11(3):189&#x2013;191. doi: 10.1038/nchembio.1735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1735</ArticleId><ArticleId IdType="pmc">PMC4397581</ArticleId><ArticleId IdType="pubmed">25622091</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, et al. Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J Cereb Blood Flow Metab. 2005;25(2):281&#x2013;290. doi: 10.1038/sj.jcbfm.9600034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.jcbfm.9600034</ArticleId><ArticleId IdType="pmc">PMC2804085</ArticleId><ArticleId IdType="pubmed">15678129</ArticleId></ArticleIdList></Reference><Reference><Citation>Bou&#xeb;t V, et al. Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse. Exp Neurol. 2007;203(2):555&#x2013;567. doi: 10.1016/j.expneurol.2006.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2006.09.006</ArticleId><ArticleId IdType="pubmed">17067578</ArticleId></ArticleIdList></Reference><Reference><Citation>Massberg S, et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med. 2010;16(8):887&#x2013;896. doi: 10.1038/nm.2184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2184</ArticleId><ArticleId IdType="pubmed">20676107</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangold A, et al. Culprit site extracellular DNA and microvascular obstruction in ST-elevation myocardial infarction [Published online June 26, 2021]. Cardiovasc Res.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvab217</ArticleId><ArticleId IdType="pubmed">34173822</ArticleId></ArticleIdList></Reference><Reference><Citation>Franck G, et al. Roles of PAD4 and NETosis in experimental atherosclerosis and arterial injury: implications for superficial erosion. Circ Res. 2018;123(1):33&#x2013;42. doi: 10.1161/CIRCRESAHA.117.312494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.312494</ArticleId><ArticleId IdType="pmc">PMC6014872</ArticleId><ArticleId IdType="pubmed">29572206</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta AK, et al. Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. FEBS Lett. 2010;584(14):3193&#x2013;3197. doi: 10.1016/j.febslet.2010.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2010.06.006</ArticleId><ArticleId IdType="pubmed">20541553</ArticleId></ArticleIdList></Reference><Reference><Citation>Novotny J, et al. Thrombus NET content is associated with clinical outcome in stroke and myocardial infarction. Neurology. 2020;94(22):e2346&#x2013;e2360. doi: 10.1212/WNL.0000000000009532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009532</ArticleId><ArticleId IdType="pubmed">32434865</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasutomo K, et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet. 2001;28(4):313&#x2013;314. doi: 10.1038/91070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/91070</ArticleId><ArticleId IdType="pubmed">11479590</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakkim A, et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A. 2010;107(21):9813&#x2013;9818. doi: 10.1073/pnas.0909927107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0909927107</ArticleId><ArticleId IdType="pmc">PMC2906830</ArticleId><ArticleId IdType="pubmed">20439745</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez-Alc&#xe1;zar M, et al. Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies. J Thromb Haemost. 2015;13(5):732&#x2013;742. doi: 10.1111/jth.12796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12796</ArticleId><ArticleId IdType="pubmed">25418346</ArticleId></ArticleIdList></Reference><Reference><Citation>Leffler J, et al. Decreased neutrophil extracellular trap degradation in shiga toxin-associated haemolytic uraemic syndrome. J Innate Immun. 2017;9(1):12&#x2013;21. doi: 10.1159/000450609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000450609</ArticleId><ArticleId IdType="pmc">PMC6738868</ArticleId><ArticleId IdType="pubmed">27784011</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofbauer TM, et al. Deoxyribonuclease 1 Q222R single nucleotide polymorphism and long-term mortality after acute myocardial infarction. Basic Res Cardiol. 2021;116(1):29. doi: 10.1007/s00395-021-00864-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-021-00864-w</ArticleId><ArticleId IdType="pmc">PMC8064981</ArticleId><ArticleId IdType="pubmed">33891165</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez-Alc&#xe1;zar M, et al. Host DNases prevent vascular occlusion by neutrophil extracellular traps. Science. 2017;358(6367):1202&#x2013;1206. doi: 10.1126/science.aam8897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aam8897</ArticleId><ArticleId IdType="pubmed">29191910</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorch SK, Kubes P. An emerging role for neutrophil extracellular traps in noninfectious disease. Nat Med. 2017;23(3):279&#x2013;287. doi: 10.1038/nm.4294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4294</ArticleId><ArticleId IdType="pubmed">28267716</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi K, et al. Global brain inflammation in stroke. Lancet Neurol. 2019;18(11):1058&#x2013;1066. doi: 10.1016/S1474-4422(19)30078-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30078-X</ArticleId><ArticleId IdType="pubmed">31296369</ArticleId></ArticleIdList></Reference><Reference><Citation>Denorme F, et al. von Willebrand factor and platelet glycoprotein Ib: a thromboinflammatory axis in stroke. Front Immunol. 2019;10:2884. doi: 10.3389/fimmu.2019.02884.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02884</ArticleId><ArticleId IdType="pmc">PMC6928043</ArticleId><ArticleId IdType="pubmed">31921147</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyer MR, et al. Deep vein thrombosis in mice is regulated by platelet HMGB1 through release of neutrophil-extracellular traps and DNA. Sci Rep. 2018;8(1):2068. doi: 10.1038/s41598-018-20479-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20479-x</ArticleId><ArticleId IdType="pmc">PMC5794752</ArticleId><ArticleId IdType="pubmed">29391442</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, et al. Tumor-derived HMGB1 induces CD62Ldim neutrophil polarization and promotes lung metastasis in triple-negative breast cancer. Oncogenesis. 2020;9(9):82. doi: 10.1038/s41389-020-00267-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41389-020-00267-x</ArticleId><ArticleId IdType="pmc">PMC7499196</ArticleId><ArticleId IdType="pubmed">32943604</ArticleId></ArticleIdList></Reference><Reference><Citation>Liesz A, et al. DAMP signaling is a key pathway inducing immune modulation after brain injury. J Neurosci. 2015;35(2):583&#x2013;598. doi: 10.1523/JNEUROSCI.2439-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2439-14.2015</ArticleId><ArticleId IdType="pmc">PMC4293412</ArticleId><ArticleId IdType="pubmed">25589753</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein RS, et al. Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock. 2006;25(6):571&#x2013;574. doi: 10.1097/01.shk.0000209540.99176.72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.shk.0000209540.99176.72</ArticleId><ArticleId IdType="pubmed">16721263</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuhmann MK, et al. Danger-associated molecular patterns are locally released during occlusion in hyper-acute stroke. Brain Behav Immun Health. 2021;15:100270. doi: 10.1016/j.bbih.2021.100270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100270</ArticleId><ArticleId IdType="pmc">PMC8474429</ArticleId><ArticleId IdType="pubmed">34589775</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, et al. Prognostic value of plasma HMGB1 in ischemic stroke patients with cerebral ischemia-reperfusion injury after intravenous thrombolysis. J Stroke Cerebrovasc Dis. 2020;29(9):105055. doi: 10.1016/j.jstrokecerebrovasdis.2020.105055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2020.105055</ArticleId><ArticleId IdType="pubmed">32807461</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark K, et al. Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice. Blood. 2016;128(20):2435&#x2013;2449. doi: 10.1182/blood-2016-04-710632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2016-04-710632</ArticleId><ArticleId IdType="pmc">PMC5147023</ArticleId><ArticleId IdType="pubmed">27574188</ArticleId></ArticleIdList></Reference><Reference><Citation>Roussel BD, et al. HMGB-1 promotes fibrinolysis and reduces neurotoxicity mediated by tissue plasminogen activator. J Cell Sci. 2011;124(12):2070&#x2013;2076. doi: 10.1242/jcs.084392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.084392</ArticleId><ArticleId IdType="pubmed">21610098</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen C, et al. Neutrophil cerebrovascular transmigration triggers rapid neurotoxicity through release of proteases associated with decondensed DNA. J Immunol. 2012;189(1):381&#x2013;392. doi: 10.4049/jimmunol.1200409.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1200409</ArticleId><ArticleId IdType="pmc">PMC3381844</ArticleId><ArticleId IdType="pubmed">22661091</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood DD, et al. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities. Lab Invest. 2008;88(4):354&#x2013;364. doi: 10.1038/labinvest.3700748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.3700748</ArticleId><ArticleId IdType="pubmed">18227806</ArticleId></ArticleIdList></Reference><Reference><Citation>Acharya NK, et al. Neuronal PAD4 expression and protein citrullination: possible role in production of autoantibodies associated with neurodegenerative disease. J Autoimmun. 2012;38(4):369&#x2013;380. doi: 10.1016/j.jaut.2012.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2012.03.004</ArticleId><ArticleId IdType="pubmed">22560840</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastronardi FG, et al. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation. J Neurosci. 2006;26(44):11387&#x2013;11396. doi: 10.1523/JNEUROSCI.3349-06.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3349-06.2006</ArticleId><ArticleId IdType="pmc">PMC6674531</ArticleId><ArticleId IdType="pubmed">17079667</ArticleId></ArticleIdList></Reference><Reference><Citation>Carminita E, et al. DNAse-dependent, NET-independent pathway of thrombus formation in vivo. Proc Natl Acad Sci U S A. 2021;118(28):e2100561118. doi: 10.1073/pnas.2100561118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2100561118</ArticleId><ArticleId IdType="pmc">PMC8285961</ArticleId><ArticleId IdType="pubmed">34260389</ArticleId></ArticleIdList></Reference><Reference><Citation>Popowicz N, et al. Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The Alteplase Dose Assessment for Pleural Infection Therapy project. Ann Am Thorac Soc. 2017;14(6):929&#x2013;936. doi: 10.1513/AnnalsATS.201609-673OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201609-673OC</ArticleId><ArticleId IdType="pubmed">28324671</ArticleId></ArticleIdList></Reference><Reference><Citation>Mestas J, Hughes CCW. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172(5):2731&#x2013;2738. doi: 10.4049/jimmunol.172.5.2731.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.172.5.2731</ArticleId><ArticleId IdType="pubmed">14978070</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell RA, et al. Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3. Blood. 2019;133(19):2013&#x2013;2026. doi: 10.1182/blood-2018-09-873984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2018-09-873984</ArticleId><ArticleId IdType="pmc">PMC6509546</ArticleId><ArticleId IdType="pubmed">30723081</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton EA, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136(10):1169&#x2013;1179. doi: 10.1182/blood.2020007008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007008</ArticleId><ArticleId IdType="pmc">PMC7472714</ArticleId><ArticleId IdType="pubmed">32597954</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell RA, et al. Clots are potent triggers of inflammatory cell gene expression: indications for timely fibrinolysis. Arterioscler Thromb Vasc Biol. 2017;37(10):1819&#x2013;1827. doi: 10.1161/ATVBAHA.117.309794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.117.309794</ArticleId><ArticleId IdType="pmc">PMC5620127</ArticleId><ArticleId IdType="pubmed">28775073</ArticleId></ArticleIdList></Reference><Reference><Citation>Manne BK, et al. Platelet gene expression and function in patients with COVID-19. Blood. 2020;136(11):1317&#x2013;1329. doi: 10.1182/blood.2020007214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007214</ArticleId><ArticleId IdType="pmc">PMC7483430</ArticleId><ArticleId IdType="pubmed">32573711</ArticleId></ArticleIdList></Reference><Reference><Citation>Denorme F, et al. COVID-19 patients exhibit reduced procoagulant platelet responses. J Thromb Haemost. 2020;18(11):3067&#x2013;3073. doi: 10.1111/jth.15107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15107</ArticleId><ArticleId IdType="pmc">PMC7646270</ArticleId><ArticleId IdType="pubmed">32945081</ArticleId></ArticleIdList></Reference><Reference><Citation>Denorme F, et al. Hyperglycemia exacerbates ischemic stroke outcome independent of platelet glucose uptake. J Thromb Haemost. 2021;19(2):536&#x2013;546. doi: 10.1111/jth.15154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15154</ArticleId><ArticleId IdType="pmc">PMC7902465</ArticleId><ArticleId IdType="pubmed">33118271</ArticleId></ArticleIdList></Reference><Reference><Citation>Denorme F, et al. Platelet necrosis mediates ischemic stroke outcome in mice. Blood. 2020;135(6):429&#x2013;440. doi: 10.1182/blood.2019002124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2019002124</ArticleId><ArticleId IdType="pmc">PMC7005363</ArticleId><ArticleId IdType="pubmed">31800959</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>